AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.27B |
| 2 |
Visa
V
|
+$459M |
| 3 |
Nike
NKE
|
+$410M |
| 4 |
Etsy
ETSY
|
+$311M |
| 5 |
Gen Digital
GEN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$606M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$492M |
| 3 |
Procter & Gamble
PG
|
+$389M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$310M |
| 5 |
IQVIA
IQV
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.23% |
| 2 | Healthcare | 14.38% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 12.81% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Hope Bancorp
HOPE
$1.79B
| $3.04M | ﹤0.01% |
214,106
+11,840
| +6% | +$179K |
|
1927
Coca-Cola Consolidated
COKE
$12.5B
| $3.03M | ﹤0.01% |
75,340
+6,100
| +9% | +$215K |
|
|
XPDIU
1928
DELISTED
Power & Digital Infrastructure Acquisition Corp. Unit
XPDIU
| $3.03M | ﹤0.01% |
300,000
| – | – |
|
1929
Sarepta Therapeutics
SRPT
$1.57B
| $3.03M | ﹤0.01% |
38,928
-9,537
| -20% | -$723K |
|
1930
Futu Holdings
FUTU
$14.7B
| $3.02M | ﹤0.01% |
16,840
+14,124
| +520% | +$2.05M |
|
1931
TechTarget
TTGT
$325M
| $3.01M | ﹤0.01% |
38,901
+2,320
| +6% | +$167K |
|
1932
Rush Enterprises Class A
RUSHA
$6.2B
| $3.01M | ﹤0.01% |
104,368
+27,720
| +36% | +$887K |
|
1933
Tandem Diabetes Care
TNDM
$1.34B
| $3.01M | ﹤0.01% |
30,896
-1,341
| -4% | -$120K |
|
1934
Yext
YEXT
$547M
| $3.01M | ﹤0.01% |
210,467
+50
| +0% | +$696 |
|
1935
Lantheus
LNTH
$6.49B
| $3.01M | ﹤0.01% |
108,760
-6,675
| -6% | -$153K |
|
1936
Equitable Holdings
EQH
$13B
| $3M | ﹤0.01% |
98,448
-139,301
| -59% | -$4.54M |
|
|
SWTX
1937
DELISTED
SpringWorks Therapeutics
SWTX
| $2.98M | ﹤0.01% |
36,200
+2,000
| +6% | +$152K |
|
1938
PRA Group
PRAA
$663M
| $2.98M | ﹤0.01% |
77,390
+4,720
| +6% | +$181K |
|
1939
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $2.96M | ﹤0.01% |
86,797
+3,217
| +4% | +$117K |
|
1940
United Natural Foods
UNFI
$3.08B
| $2.96M | ﹤0.01% |
80,123
+620
| +0.8% | +$22.6K |
|
1941
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
| $2.96M | ﹤0.01% |
26,768
-1,386
| -5% | -$153K |
|
1942
MGE Energy Inc
MGEE
$3B
| $2.96M | ﹤0.01% |
39,720
-4,900
| -11% | -$365K |
|
1943
Qfin Holdings
QFIN
$1.69B
| $2.96M | ﹤0.01% |
70,624
-145,685
| -67% | -$4.44M |
|
|
AVNS
1944
DELISTED
Avanos Medical
AVNS
| $2.94M | ﹤0.01% |
80,924
-44,268
| -35% | -$1.83M |
|
1945
Stem
STEM
$48.4M
| $2.94M | ﹤0.01% |
+4,080
| New | +$2.22M |
|
1946
JFrog
FROG
$9.66B
| $2.93M | ﹤0.01% |
+64,373
| New | +$2.9M |
|
1947
Citi Trends
CTRN
$555M
| $2.92M | ﹤0.01% |
33,543
-245,180
| -88% | -$22.6M |
|
1948
Inovio Pharmaceuticals
INO
$55.7M
| $2.92M | ﹤0.01% |
26,208
+7,966
| +44% | +$765K |
|
1949
First Business Financial Services
FBIZ
$587M
| $2.91M | ﹤0.01% |
107,608
+40,534
| +60% | +$1.07M |
|
|
OSH
1950
DELISTED
Oak Street Health, Inc.
OSH
| $2.91M | ﹤0.01% |
49,710
+29,496
| +146% | +$1.76M |
|
Similar funds
AllianceBernstein's Q2 2021 Portfolio in Review
As of Q2 2021, AllianceBernstein held 3,558 positions worth $249B, up 9.2% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AllianceBernstein's Q2 2021 filing shows 327 new, 1,436 increased, 1,300 reduced and 241 closed positions. Its largest new stake was Coinbase: 547,649 shares worth $139M. The largest sale was Regeneron Pharmaceuticals, an estimated $606M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q2 2021 buy was Coinbase: 547,649 shares worth $139M.
- AllianceBernstein added most to Amazon in Q2 2021, an estimated $1.27B increase.
- AllianceBernstein's biggest Q2 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $606M.
- AllianceBernstein fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $43.3M.
- AllianceBernstein's ten largest holdings make up 24% of its $249B portfolio in Q2 2021.
- AllianceBernstein opened 327 new positions and closed 241 in Q2 2021.
- AllianceBernstein's portfolio value rose 9.2% quarter-over-quarter to $249B.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.